FDA requires stronger warnings about breast implant risks

México Noticias Noticias

FDA requires stronger warnings about breast implant risks
México Últimas Noticias,México Titulares
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 86%

The new labeling will include a boxed warning, one of the strongest of its kind because of its visibility, informing patients of the significant risks of breast implants, including rupture and the potential for systemic illnesses and a type of cancer.

The FDA is also requiring all patients to review a safety checklist to ensure they are aware of not just the risks of implants, but also when they should and shouldn’t be used, as well as surgical alternatives, especially for mastectomy patients. The hope is that the checklist will provide valuable safety information that patients may never see on the implants’ box, since it’s something that’s opened in the operating room and then thrown away.

The agency will also restrict sales and distribution of implants to only doctors and medical facilities that provide patients with specific safety information.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

NBCNews /  🏆 10. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kidsFDA panel backs Pfizer’s low-dose COVID-19 vaccine for kidsBREAKING: FDA advisers endorse Pfizer’s COVID-19 vaccine for children ages 5 to 11. The FDA isn’t bound by the recommendation and is expected to make a decision within days. The kid-sized dose is a third of the Pfizer shot that adults received.
Leer más »

FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids Ages 5-11FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids Ages 5-11U.S. health advisers have endorsed kid-size doses of Pfizer's COVID-19 vaccine for younger children.
Leer más »

COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsCOVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Leer más »

FDA panel OKs low-dose Pfizer vaccine for kids 5 to 11FDA panel OKs low-dose Pfizer vaccine for kids 5 to 11The move, if signed off on by the FDA, would expand eligibility to 28 million children in the U.S.
Leer más »

FDA advisers back Pfizer's COVID vaccine for kids 5 to 11FDA advisers back Pfizer's COVID vaccine for kids 5 to 11The CDC must also weigh in before younger children can be vaccinated.
Leer más »



Render Time: 2025-03-10 02:58:46